Morgans names 3 small-cap ASX shares to buy

Let's see why the broker is bullish on these under the radar shares.

If you have a higher than average tolerance for risk, then it could be worth hearing what Morgans has to say about the small-cap ASX shares in this article.

Here's why the broker currently rates them as buys:

Happy man working on his laptop.

Image source: Getty Images

Airtasker Ltd (ASX: ART)

Morgans was pleased with this small jobs marketplace provider's performance in the first half of FY 2026. It notes that the company delivered double-digit revenue growth thanks to solid performances at home and overseas.

In response, the broker has retained its buy rating with a trimmed price target of 51 cents. It said:

It was a resilient 1H26 result for Airtasker, delivering ~13.5% group revenue growth to ~A$29m. Its established marketplaces saw EBITDA growth of ~11% to ~A$15m. Domestic metrics appear sound (e.g. uptick in booked tasks and brand salience), and we remain pleased with the momentum seen in ART's offshore marketplace build-out (UK/US revenue +85% and 380% on the pcp respectively).

We make minor adjustments to our topline forecasts (details below), we also include the additional $5m cash marketing costs into our 2H numbers along with the recent capital raise. Our price target is lowered to A$0.51. Buy maintained.

Epiminder Ltd (ASX: EPI)

Another small-cap ASX share that has been given the thumbs up by Morgans is Epiminder.

Morgans notes that there were no surprises with its half-year results, with everything in line with expectations. As a result, the broker has reaffirmed its speculative buy rating and $2.33 price target on its shares. It said:

Debut 1HFY26 results held no material surprises relative to IPO disclosures, and are more strategically important than financially complex. Since listing, EPI has secured a favourable Medicare reimbursement ruling, completed the first US Minder implant and signed nine Tier-1 US centres for DETECT, albeit enrolment remains early (3 patients to date).

Cash runway is confirmed through DETECT completion and G1 development into CY28, with execution on enrolment cadence now the key swing factor for sentiment. We make no changes to our FY26-28 forecasts or A$2.33 DCF-based target price. SPECULATIVE BUY rating maintained.

SomnoMed Ltd (ASX: SOM)

A third small-cap ASX share that is being tipped as a buy by Morgans is SomnoMed.

It highlights that the sleep disorder treatment company has started FY 2026 positively and is in a good position to achieve its full-year guidance.

As a result, it has retained its speculative buy rating and 99 cents price target on its shares. It commented:

SOM's 1H26 result places the company in a strong position to deliver at least the low end of its FY26 guidance, with clear upside potential. The half delivered solid double-digit revenue growth, meaningful operating leverage and significantly improved manufacturing efficiency, giving SOM a structurally strong base heading into 2H.

With around half of revenue and the majority of EBITDA already achieved in 1H, the 2H requirements to meet both the low and high ends of guidance appear modest and achievable. Continued momentum across Europe and North America, combined with expanded capacity and improved turnaround times, provides a credible pathway for SOM to finish the year toward the upper end of its range if current trends persist. No change to valuation or positive outlook but note upside risk as 2H progresses.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Airtasker. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Small Cap Shares

A woman in a red dress holding up a red graph.
Small Cap Shares

Hidden gems outside the ASX 200: 4 small caps with growing revenue and no debt

These fast-growing companies might be worth a look.

Read more »

Man analysing data on his laptop.
Small Cap Shares

Picking a future $20 billion ASX company: How I narrowed a field of small caps down to one

I think these shares have what it takes to grow materially in the future.

Read more »

Small kid giving a thumbs up.
Small Cap Shares

Experts expect this ASX small-cap share could rise 50% in the next 12 months

This small business could have big potential.

Read more »

Happy girl holding a plant and soil in front of ascending piles of coins.
Small Cap Shares

I went looking for the next ASX 10-bagger. These 3 shares made my shortlist

I started with the qualities that helped some of the ASX's biggest success stories grow. Then I looked for companies…

Read more »

A young woman looks happily at her phone in one hand with a selection of retail shopping bags in her other hand.
Small Cap Shares

3 reasons why this great ASX small-cap share is a buy

I think this small business could become a lot bigger.

Read more »

Male hands holding Australian dollar banknotes, symbolising dividends.
Small Cap Shares

This ASX small-cap share is predicted to deliver market-beating returns

The smallest stocks can deliver big returns.

Read more »

three children wearing superhero costumes, complete with masks, pose with hands on hips wearing capes and sneakers on a running track.
Broker Notes

3 ASX small-cap shares to buy amid sector weakness: experts

The ASX Small Ords Index has tumbled 14% in 2026 vs. a 1% fall for the broader ASX All Ords.

Read more »

Small girl giving a fist bump with a piggy bank in front of her.
Small Cap Shares

An ASX small-cap share to buy for its bright future

Investors can get excited about this stock.

Read more »